270 related articles for article (PubMed ID: 30419963)
1. Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation.
Liao P; He Y; Yang F; Luo G; Zhuang J; Zhai Z; Zhuang L; Lin Z; Zheng J; Sun E
Arthritis Res Ther; 2018 Nov; 20(1):254. PubMed ID: 30419963
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.
Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ
Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
4. Effects of the antioxidants Trolox, Tiron and Tempol on neutrophil extracellular trap formation.
Vorobjeva NV; Pinegin BV
Immunobiology; 2016 Feb; 221(2):208-19. PubMed ID: 26371849
[TBL] [Abstract][Full Text] [Related]
5. Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.
Fresneda Alarcon M; McLaren Z; Wright HL
Front Immunol; 2021; 12():649693. PubMed ID: 33746988
[TBL] [Abstract][Full Text] [Related]
6. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
Chauhan SK; Rai R; Singh VV; Rai M; Rai G
Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
Lood C; Blanco LP; Purmalek MM; Carmona-Rivera C; De Ravin SS; Smith CK; Malech HL; Ledbetter JA; Elkon KB; Kaplan MJ
Nat Med; 2016 Feb; 22(2):146-53. PubMed ID: 26779811
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.
Jonsson CA; Svensson L; Carlsten H
Clin Exp Immunol; 1999 Jun; 116(3):534-41. PubMed ID: 10361247
[TBL] [Abstract][Full Text] [Related]
9. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation.
Vlachou K; Mintzas K; Glymenaki M; Ioannou M; Papadaki G; Bertsias GK; Sidiropoulos P; Boumpas DT; Verginis P
Arthritis Rheumatol; 2016 Feb; 68(2):449-61. PubMed ID: 26414650
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.
Wolf VL; Taylor EB; Ryan MJ
Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322
[TBL] [Abstract][Full Text] [Related]
11. Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus.
Van Avondt K; Fritsch-Stork R; Derksen RH; Meyaard L
PLoS One; 2013; 8(10):e78459. PubMed ID: 24205237
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus onset in lupus-prone B6.MRL/lpr mice Is influenced by weight gain and Is preceded by an increase in neutrophil oxidative burst activity.
Toller-Kawahisa JE; Canicoba NC; Venancio VP; Kawahisa R; Antunes LM; Cunha TM; Marzocchi-Machado CM
Free Radic Biol Med; 2015 Sep; 86():362-73. PubMed ID: 26117329
[TBL] [Abstract][Full Text] [Related]
13. Trophoblast cells inhibit neutrophil extracellular trap formation and enhance apoptosis through vasoactive intestinal peptide-mediated pathways.
Calo G; Sabbione F; Vota D; Paparini D; Ramhorst R; Trevani A; Pérez Leirós C
Hum Reprod; 2017 Jan; 32(1):55-64. PubMed ID: 27932441
[TBL] [Abstract][Full Text] [Related]
14. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
15. Selected mucolytic, anti-inflammatory and cardiovascular drugs change the ability of neutrophils to form extracellular traps (NETs).
Zawrotniak M; Kozik A; Rapala-Kozik M
Acta Biochim Pol; 2015; 62(3):465-73. PubMed ID: 26291043
[TBL] [Abstract][Full Text] [Related]
16. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
[TBL] [Abstract][Full Text] [Related]
17. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Barnado A; Crofford LJ; Oates JC
J Leukoc Biol; 2016 Feb; 99(2):265-78. PubMed ID: 26658004
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydroisoquinolines: New Inhibitors of Neutrophil Extracellular Trap (NET) Formation.
Martinez NE; Zimmermann TJ; Goosmann C; Alexander T; Hedberg C; Ziegler S; Zychlinsky A; Waldmann H
Chembiochem; 2017 May; 18(10):888-893. PubMed ID: 28240414
[TBL] [Abstract][Full Text] [Related]
19. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
20. High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus.
Shi D; Li X; Chen H; Che N; Zhou S; Lu Z; Shi S; Sun L
Pathol Biol (Paris); 2014 Dec; 62(6):382-90. PubMed ID: 25239279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
